Azienda Ospedaliero Universitaria Ospedali Riuniti

Clinical trials at Azienda Ospedaliero Universitaria Ospedali Riuniti include a strong focus on respiratory tract diseases, especially asthma and idiopathic pulmonary fibrosis. These studies are designed to explore new ways to ease symptoms, reduce flare-ups, and improve day-to-day breathing for people living with chronic lung conditions.

• Testing new treatment options for asthma control and fewer exacerbations
• Evaluating therapies aimed at relieving cough in idiopathic pulmonary fibrosis
• Studying better symptom management for chronic respiratory disease

The site’s respiratory department supports research that may help improve both treatment effectiveness and quality of life for patients with long-term lung disease.

A notable part of the research portfolio centers on digestive system diseases and nutritional and metabolic diseases, with studies in non-alcoholic steatohepatitis, metabolic dysfunction-associated steatohepatitis, and related fibrosis. This work aims to better understand liver inflammation and scarring while assessing new therapies for patients with progressive metabolic liver disease.

• Investigating treatments for NASH and MASH with fibrosis
• Assessing safety and tolerability of emerging liver-directed therapies
• Exploring ways to slow disease progression and improve liver outcomes

These trials reflect an active effort to advance care for patients at risk of serious liver complications, including long-term damage and liver failure.

The site is also involved in cardiovascular diseases research, including studies in heart failure with preserved or mildly reduced ejection fraction and atrial fibrillation to help prevent stroke and systemic embolism. These trials are focused on improving protection against major cardiovascular events while balancing treatment safety.

• Evaluating new approaches for heart failure with inflammation
• Studying therapies to reduce stroke risk in atrial fibrillation
• Comparing treatment options for better cardiovascular benefit and safety

Research in this area may support more effective long-term management for patients with complex heart and circulation problems.

Neoplasms are another important research area at this hospital, with trials in prostate cancer and advanced biliary tract cancers. The studies are examining new treatment combinations and strategies to improve cancer control in patients with advanced or resistant disease.

• Testing combination treatments for advanced biliary tract cancers
• Studying therapy options for metastatic prostate cancer
• Exploring approaches for patients whose cancer has progressed after prior treatment

This oncology research is aimed at improving response rates, extending disease control, and offering better options for patients with difficult-to-treat cancers.

The clinical trial program includes virus diseases research, particularly HIV-1 infection. These studies focus on treatment strategies that may help people achieve viral suppression more quickly and maintain control over the infection with simpler long-term care.

• Evaluating treatment approaches for adults starting HIV therapy
• Studying long-term maintenance of viral suppression
• Assessing patient-friendly regimens for ongoing HIV management

Such trials support ongoing progress toward more convenient and effective HIV care.

Research at the site also covers nervous system diseases and mental disorders, including autism spectrum disorders. These studies are designed to improve understanding of social communication challenges and to test new options that may support behavioral and developmental outcomes.

• Studying therapies for core social communication difficulties in autism
• Exploring interventions that may improve behavior and daily functioning
• Advancing care in neurodevelopmental and mental health conditions

This area highlights the site’s interest in research that may help patients across childhood and adult neuropsychiatric care.